J8501 Oral aprepitant
Also known as: Emend, Oral aprepitant
Aprepitant administered orally; a neurokinin-1 receptor antagonist used to prevent nausea and vomiting, particularly in chemotherapy.
In Plain Language
Nausea and vomiting prevention pill; Antiemetic medication
Clinical Context
Used to prevent acute and delayed chemotherapy-induced nausea and vomiting. Often combined with 5-HT3 antagonists and corticosteroids.
RVU Information
CPT J8501 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J8501?
CPT J8501 (Oral aprepitant) is a J Codes (Drugs) code. Aprepitant administered orally; a neurokinin-1 receptor antagonist used to prevent nausea and vomiting, particularly in chemotherapy.
How is J8501 administered?
CPT J8501 is administered by a healthcare provider, typically via injection or infusion. Used to prevent acute and delayed chemotherapy-induced nausea and vomiting. Often combined with 5-HT3 antagonists and corticosteroids. It is used by Oncology, Internal Medicine, Gastroenterology.
When is CPT J8501 used?
Used to prevent acute and delayed chemotherapy-induced nausea and vomiting. Often combined with 5-HT3 antagonists and corticosteroids.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.